AstraZeneca - Non-adherence to cardiovascular medicine: Tackling the ‘global threat’
"Non-adherence to cardiovascular therapy is associated with increased mortality. A recent study has shown that patients who stop taking their medication experienced a five-fold increase in the number of deaths versus those who remained adherent, reinforcing the importance of tackling the non-adherence pandemic."
Reactions
(11)
Astra Zeneca
Non-adherence to cardiovascular therapy is associated with increased mortality. A recent study has shown that patients who stop taking their medication experienced a five-fold increase in the number of deaths versus those who remained adherent,2reinforcing the importance of tackling the non-adherence pandemic.